Lanean...
Rilpivirine Pharmacokinetics Without and With Darunavir/ritonavir once daily in Adolescents and Young Adults
BACKGROUND: Rilpivirine (RPV), a recently developed, once daily HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), is not currently approved for pediatric patients, but is sometimes prescribed for adolescents with multiple treatment failures, for regimen simplification or to minimize toxici...
Gorde:
| Argitaratua izan da: | Pediatr Infect Dis J |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5245132/ https://ncbi.nlm.nih.gov/pubmed/27187753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001214 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|